Antibiotic prophylaxis in catheter-associated urinary infections

New Microbiologica

Volumn 35, Issue 2, 2012, Pages 191-198

  Petronella, Pasquale ^a,b   Scorzelli, Marco ^a,b   Fiore, Andrea ^a,c   Corbisiero, Maria Carmela ^a,c   Agresti, Ettore ^a,c   Esposito, Silvano ^a,d   Freda, Fulvio ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Department of Gerontology Geriatrics and Metabolic Diseases   (Italy)

^c Unit of v General Surgery   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

Author keywords

Antibiotic prophylaxis; Levofloxacin; Urinary tract infections

Indexed keywords

OFLOXACIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLADDER CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MICROBIOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION;

ANTIBIOTIC PROPHYLAXIS; FEMALE; HUMANS; MALE; OFLOXACIN; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 84862131355     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. VAN DERWALL E., VERKOOYEN R.P., MINTJES-DE GROOT J., OOSTINGA J., VAN DIJK A., HUSTINX W.N., VERBRUGH H.A. (1992). Prophylactic ciprofloxacin for catheterassociated urinary-tract infection. Lancet. 339 (8799), 946-951.
2. TAMBYAH P.A., MAKI D.G. (2000). Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch. Intern Med. 160 (5), 678-82. (Pubitemid 30140418)
3. GODFREY H., EVANS A. (2000). Catheterization and urinary tract infections: microbiology. Br. J. Nurs. 9 (11), 682-690.
4. LAUTENBACH E., PATEL J.B., BILKERW.B., EDELSTEIN P.H., FISHMAN N.O. (2001). Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32 (8), 1162-1171. (Pubitemid 32390110)
5. DOYLE B., MAWJI Z., HORGANM., STILLMAN P., RINEHART A., BAILEY J., MULLIN E. JR. (2001). Decreasing nosocomial urinary tract infection in a large academic community hospital. Lippincotts Case Manag. 6 (3), 127-136.
6. LÉONE M., ARNAUD S., BOISSON C., BLANC-BIMAR M.C., MARTIN C. (2000). Catheter-related nosocomial urinary infections in intensive care: physiopathology, epidemiology and prevention. Ann. Fr. Anesth. Reanim. 19 (1), 23-34. (Pubitemid 30085891)
7. GODFREY H., EVANS A. (2000). Catheterization and urinary tract infections: microbiology. Br. J. Nurs. 9 (11), 682-690.
8. LONG C.O., ANDERSON C., GREENBERG E.A., WOOMER N. (2002). Defining and monitoring indwelling catheter-related urinary tract infections. Home Healthc. Nurse. 20 (4), 255-262.
9. LEE Y.L., CESARIO T., MCCAULEY V., FLIONIS L., PAX A., THRUPP L. (1998). Low-level colonization and infection with ciprofloxacin-resistant gram-negative bacilli in a skilled nursing facility. Am. J. Infect. Control. 26 (6), 552-557. (Pubitemid 28565070)
10. SAINT S., LIPSKY B.A. (1999). Preventing Catheter-related Bacteriuria. Should we? Can we? How? Arch. Inern. Med. 159, 800-807.
11. SAFDAR N., MAKI D.G. (2002). The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann. Intern. Med. 136 (11), 834-844. (Pubitemid 34568654)
12. SALVESTRINI F., OLIVA G., MATTEI FM. (1996). Oral therapy with ciprofloxacin in the prophylaxis of urinary infections in surgical patients with permanent bladder catheter. Minerva Chir. 51 (7-8), 625-628. (Pubitemid 26361648)
13. WINTER M., HELMS B., HARRINGTON L., LUQUIRE R., MCVAY T., RHODES N. (2009). Eliminating catheterassociated urinary tract infections: part I. Avoid catheter use. J. Healthc. Qual. 31 (6): 8-12.
14. RHODES N., MCVAY T., HARRINGTON L., LUQUIRE R., WINTERM., HELMS B. (2009). Eliminating catheterassociated urinary tract infections: part II. Limit duration of catheter use. J. Healthc. Qual. 31 (6), 13-17.
15. POISSON S.N., JOHNSTON S.C., JOSEPHSON S.A. (2010). Urinary tract infections complicating stroke: mechanisms, consequences, and possible solutions. Stroke. 41 (4), 180-184.
16. HAMEED A., CHINEGWUNDOH F., THWAINI A. (2010). Prevention of catheter-related urinary tract infections. Br. J. Hosp. Med. (Lond). 71 (3), 148-152.
17. ROGHMANN M.C., WALLIN M.T., GORMAN P.H., JOHNSON J.A. (2006). Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction. Arch. Phys. Med. Rehabil. 87 (10), 1305-1309. (Pubitemid 44470768)
18. KUSTER S.P., HASSE B., HUEBNER V., BANSAL V., ZBINDEN R., RUEF C., LEDERGERBER B., WEBER R. (2010). Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection. 38 (1), 33-40.